Business Context and Reporting Period
This Form 8-K was filed by Greatbatch, Inc. on November 1, 2007, reporting events occurring on October 29 and October 30, 2007. The filing details two material asset acquisitions intended to expand the company's portfolio in wireless sensor solutions and single-use medical device products.
Key Financial Metrics and Transaction Values
- Quan Emerteq Acquisition: Agreed purchase price of approximately $55 million in cash, subject to working capital adjustments.
- IntelliSensing Acquisition: Agreed purchase price of approximately $3.9 million in cash.
- Total Transaction Value: Approximately $58.9 million in cash consideration.
- Financial Impact: The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures for the reporting period. It only states that press releases contain forward-looking statements regarding the expected effect on earnings per share and sales.
Material Changes and Acquisitions
The primary material change is the entry into definitive agreements for two acquisitions:
- Quan Emerteq LLC: A Minnesota-based company designing and manufacturing single-use medical device products for vascular, cardiac rhythm management, and neurostimulation markets. Closing is expected in November 2007.
- IntelliSensing LLC: A New York-based company established in 2005 that designs and manufactures wireless sensor solutions measuring temperature, pressure, and flow.
Guidance, Outlook, and Risks
Management expects the Quan Emerteq transaction to close in November 2007. The acquisitions are described as complementary to Greatbatch's existing business. The filing includes significant forward-looking statements regarding anticipated earnings per share and sales impacts, which are based on current assumptions.
Risks and Contingencies:
- Closing of the Quan Emerteq transaction is subject to satisfaction or waiver of several conditions.
- Risk that acquisitions may not be completed or may be delayed.
- Risk that expected financial and strategic benefits may not be realized in a timely manner or at all.
- Greatbatch disclaims any obligation to update forward-looking statements except as required by law.
Investor Verification Checklist
- Verify the final closing status of the Quan Emerteq acquisition, as it was subject to conditions as of the filing date.
- Review the definitive Asset Purchase Agreement (Exhibit 2.1) for specific working capital adjustment mechanisms affecting the $55 million price.
- Monitor subsequent filings for actual financial impact on earnings per share and sales, as specific figures were not provided in this report.
- Confirm the integration progress of IntelliSensing's wireless sensor technology into Greatbatch's product lines.